CAPA Training and Causes of Warning Letters due to Lack of Comprehension Webinar - By AtoZ Compliance Seminar training classes conferences & workshops presented by AtoZ Compliance register for training on FindaSeminar.com

Home

Add your seminars

Training Calendar Creator Seminar Venues Training Provider Directory
 

New Seminar Search:  

 

Helpful links

find similar training...
Search by state...
Customer Support


Do you need help finding the right class, date, or location or other assistance?

Request information about upcoming training seminars workshops and conferences in   and other cities listed on FindaSeminar.com Submit a support request and receive a prompt reply.

We guarantee this AtoZ Compliance training seminar

We are an authorized partner of AtoZ Compliance

 

Price protection. The price to attend CAPA Training and Causes of Warning Letters due to Lack of Comprehension Webinar - By AtoZ Compliance is set by the training providerThere is no added charge for our services.

We honor most training provider coupons
*.   Call  a representative to see if your discount coupon applies.


Privacy. Your personal information won't be shared with anyone but the training provider AtoZ Compliance.


Security. When you register for this seminar on FindaSeminar.com your personal data and payment information is safely collected and processed using secure SSL encryption technology.

Flexibility. FindaSeminar.com offers you three ways to register for CAPA Training and Causes of Warning Letters due to Lack of Comprehension Webinar - By AtoZ Compliance seminar by AtoZ Compliance.
Register online, by phone (800) 349-1935,or fax (800) 712-5569
Who should attend CAPA Training and Causes of Warning Letters due to Lack of Comprehension Webinar - By AtoZ Compliance
Auditors, Inspectors, Regulatory Personnel, Quality and Documentation Personnel, Operations and Development Personnel
Reviews
Write and read AtoZ Compliance reviews and reviews about the training seminar CAPA Training and Causes of Warning Letters due to Lack of Comprehension Webinar - By AtoZ Compliance on the Seminar News Network and the Training News Network.
 

Frequently asked questions and registration options for the training seminar CAPA Training and Causes of Warning Letters due to Lack of Comprehension Webinar - By AtoZ Compliance

 
Find Training Near You
Use our clickable map to find training near you
Use Our Clickmap
 
hotel seminars meeting space directory
hotel meeting space training facilities restaurant and lodging

 
 
 

request on site training details for the CAPA Training and Causes of Warning Letters due to Lack of Comprehension Webinar - By AtoZ Compliance seminarRequest on site training

CAPA Training and Causes of Warning Letters due to Lack of Comprehension Webinar - By AtoZ Compliance  

 Email information about this seminar CAPA Training and Causes of Warning Letters due to Lack of Comprehension Webinar - By AtoZ Compliance by AtoZ Compliance to yourself your manager or associatesEmail this event... View and register for other training seminars like CAPA Training and Causes of Warning Letters due to Lack of Comprehension Webinar - By AtoZ Compliance by AtoZ Compliance on FindaSeminar.com See similar training.. Find and register for other training seminars by AtoZ Compliance on FindaSeminar.com Other seminars from AtoZ Compliance

By:

training seminars by AtoZ Compliance AtoZ Compliance   

For:

Auditors, Inspectors, Regulatory Personnel, Quality and Documentation Personnel, Operations and Development Personnel

Cost:   

see Registration info for seminar cost, group discount etc.

Seminar Summary:

Implementing an effective corrective actions or preventive action capable of meeting QS Regulations and satisfying quality assurance and GMP/GDP documentation requirements is critical and all too often not followed in the specified sequence which has a negative effect when CAPA systems are inspected. (see full course description)

 
 
 

 Seminar / Training class dates & locations

 

 

No seminar dates for this event are currently scheduled.  Please use the seminars search box above or choose one of the following additional training search options to find similar training.

Providers course catalog

Find seminars by state

Find seminars by city

Request on site training

Use Advanced Search


 

 
 

print the agenda print agenda for the CAPA Training and Causes of Warning Letters due to Lack of Comprehension Webinar - By AtoZ Compliance seminar

 

Training Course Syllabus:


CAPA Training and Causes of Warning Letters due to Lack of Comprehension

Overview

CAPA (Corrective and Preventative Actions) did not originate in the Pharmaceutical and Medical Device industry or the Automobile Industry as most folks post on the Internet. The program to make effective corrections and ensure that preventative applications were incorporated was in use way back in the 60s by NASA and the FAA to enhance safety but was not labeled CAPA even though the intent was the same.

A timely, well documented, Corrective / Preventive Action program validates a quality system that is not only capable of identifying potential problems but also effectively correcting problems when incidents do occur and as part of the Continuous Quality Improvement program, correcting potential problems prior to occurrence. Adequate incident tracking is the primary foundational element for an effective CAPA FDA.

“Proper” completion of the required forms in the “proper” order as described in the corporate directives and site procedures is what is required to remediate and prevent future observations by auditors and inspectors who have found numerous implementation issues and execution as result of variances in overall comprehension (failure to establish and maintain an adequate CAPA program). Examples are presented during the webinar.

Why Should You Attend

A vast majority of the current industry deficiencies which have led to isolated 483s, Warning Letters and Consent Decrees are the result of deficient technical documentation and effective means of assessing various elements of CAPA expectations for products produced and distributed under the FDA approval process.

How do you know that your FDA CAPA training procedure(s) that address the requirements of the quality system regulation have been technically defined, documented and implemented to determine if appropriate sources of product and quality assurance are being identified and that the data from these sources are being analyzed and documented in an easy to understand technical report to identify existing product and quality problems that may require corrective action and/or preventative action?

Areas Covered In This Webinar

“PROPER”

Too often regulatory documents are written using subjective terminology and grammar (first person, pronouns and adverbs) instead of objective, technical descriptions of the element being addressed (stick to the facts). Lack of technical writing skills has contributed to the majority of the current submission rejections, 483s, warning letters and consent decrees - see FDA examples at end of presentation. GMP controlled documents must be written in a way that will be clear to the jury when presented in a court case, as opposed to writing like “we are having a conversation”. Who in this case is “we”, the head of quality or a janitor?

How to determine if sources of product and quality information that may show unfavorable trends have been identified as well as confirming that data from tracking system, complaint handling or other sources are organized to identify potential product and quality assurance program that may require preventive action that would be easily understood by a third party reviewer (FDA inspector).

"CAPA"

Implementing an effective corrective actions or preventive action capable of meeting QS Regulations and satisfying quality assurance and GMP/GDP documentation requirements is accomplished in nine basic steps. The order of the listed activities is critical and all too often not followed in the specified sequence which has a negative effect when CAPA systems are inspected. Need to understand the difference between correction and corrective action.

Learning Objectives

Identification of the incident - Criticality of the Incident Tracking System separate from deviation tracking.
Evaluation of the impact or magnitude of the incident
Initiation and Risk Assessment to demonstrate compliance with Quality Systems Regulations
Investigation procedure to assess various strategies in accordance with current regulatory expectations
Root Cause Analysis training by avoiding subjective thinking to generate objective documentation
Action Plan generation listing the tasks, metric applications and acceptance criteria for each activity
Implementation Plan example needed to accomplish the Corrective or Preventive Action Plan
Verification using stand-alone documentation practices of for objective evidence to meet cGMP regulations
Effectiveness monitoring plan to demonstrate the corrective action and/or preventive action is performing as anticipated preventing reoccurrence or initial occurrence of the identified issue.
How to verify that appropriate statistical methods are employed (where necessary) to detect recurring quality problems and determine if the results of analyses are compared across different data sources to identify and develop the extent of product and quality problems
How to determine if routine company procedures as well as failure investigation procedures have been effectively implemented and are being followed (re-training is NOT an acceptable routine corrective action for operator errors) as well as how to assess if the degree to which quality problems or nonconforming products requiring an evaluation and an investigation is investigated commensurate with the significance and risk of the nonconformity along with patient risk. If the evaluations or investigations are conducted to determine root cause, how do you ensure the accuracy of the conclusion, since so many times the corrective action has been shown to be ineffective as noted in the 483 observations. Of course our quality systems must demonstrate that we are preventing distribution of nonconforming product.
So what are we doing to determine if appropriate actions have been taken for significant product and quality problems as identified by our quality system incident tracking system?
How are we demonstrating that our corrective and preventive actions were going to be effective and verified or validated prior to implementation (initiation of the change control)? We have to confirm that corrective and preventive actions do not adversely affect the finished device or impact what was submitted in our regulatory submission.
Examples of how successful companies have verified that corrective and preventive actions for product and quality problems were implemented and documented in accordance with FDA expectations.
All the above help us to determine and demonstrate that our data associated with nonconforming product and quality problems and corrective and preventive actions has been properly disseminated, including dissemination for management review.

Who Will Benefit

Auditors
Inspectors
Regulatory Personnel
Quality and Documentation Personnel
Operations and Development Personnel

Speakers Profile

Jerry Dalfors has extensive (40+ years) of business administration, consultative, technical and managerial experience in the development and manufacture of highly regulated biopharmaceutical products including injectables, biologics, medical devices and oral dosages. He has held permanent employee, temporary employee and company representative management positions with a multitude of the major pharmaceutical and biotechnology companies in the US.

He has worked with or assisted more than two dozen companies with the establishment of controlled document/quality systems, FDA briefing and submittal documents, project management of several multimillion dollar projects including design, start-up and validation to assure fast track FDA approval by maintaining strict regulatory compliance during all phases of engineering, construction, commissioning and validation, and has written numerous submission documents for product, process and facility approval/licensing which also required the development of quality systems which included customer complaint management, deviation management, CAPA and associated site wide employee training.

Each of his projects have been received and accepted by the FDA and other regulatory agencies. Jerry is considered an expert in most all aspects of the biopharmaceutical and medical device industry and has trained many FDA field inspectors on a variety of topics. None of his work has ever received a 483 but has corrected and prevented many along with Warning Letter remediation

Seminar Summary:

Implementing an effective corrective actions or preventive action capable of meeting QS Regulations and satisfying quality assurance and GMP/GDP documentation requirements is critical and all too often not followed in the specified sequence which has a negative effect when CAPA systems are inspected. (see full course description)

print this agenda print agenda for the CAPA Training and Causes of Warning Letters due to Lack of Comprehension Webinar - By AtoZ Compliance training seminar

 view dates and locations for this seminar

 

 
 
 AtoZ Compliance training and seminar course catalog

Click any title to view upcoming AtoZ Compliance training event dates and locations, class syllabus and other seminar details

 

     
 

 
     

 

  Also try the advanced seminar search tool

   FindaSeminar HomeComputer Training

unix training
training classes

 © 2002-2018 FindaSeminar.com™ All Rights Reserved.  Terms of Use |  Privacy Policy |  Training News Network